Advertisement Advertisement
Advertisement Advertisement

LanzaTech and Twelve partner to produce the world’s first polypropylene from CO2

In the United States (US) biotechnology developer and carbon recycler LanzaTech Inc., and carbon transformation company Twelve (previously known as Opus 12) have partnered to transform carbon dioxide (CO2) emissions into polypropylene (PP), a key polymer used for medical devices including syringes and IV bags, as well as for large-scale applications in automotive, furniture, textiles and other everyday products.

In the United States (US) biotechnology developer and carbon recycler LanzaTech Inc., and carbon transformation company Twelve (previously known as Opus 12) have partnered to transform carbon dioxide (CO2) emissions into polypropylene (PP), a key polymer used for medical devices including syringes and IV bags, as well as for large-scale applications in automotive, furniture, textiles and other everyday products (photo courtesy LanzaTech).

Twelve’s carbon transformation technology converts CO2 into materials that are traditionally made from fossil fuels. The company helps brands eliminate emissions by replacing the petrochemicals in their products and supply chains with “CO2Made” carbon negative chemicals and materials, as well as carbon-neutral fuels.

Polypropylene is a key material for essential medical supplies and for many products we rely on in our daily lives. Today, 100 percent of new polypropylene in use worldwide is made from petrochemicals. We now have a way to produce this critical material from CO2 and water instead of from fossil fuels, with no tradeoffs in quality, efficacy, or performance. Replacing all of the world’s fossil polypropylene production with CO2Made polypropylene would reduce carbon emissions by an estimated 700 million tons per year or more, said Dr Etosha Cave, Chief Science Officer at Twelve.

LanzaTech’s carbon recycling “Pollution To Products” technology uses nature-based solutions to produce ethanol and other materials from waste carbon sources. The partnership will bring together the two platform technologies to enable additional product development from CO2 streams, representing just one of many pathways to scale carbon transformation solutions.

By harnessing biology, we can leverage the power of nature to solve a very modern problem. The overabundance of CO2 in our atmosphere has pushed our planet into a state of emergency. We need all carbon transformation solutions to turn this liability into an opportunity, keeping fossil resources in the ground, and our climate safe for everyone, said Dr Jennifer Holmgren, CEO of LanzaTech.

To pursue the partnership, Twelve and LanzaTech have been awarded a US$200 000 grant from Impact Squared, a US$1.1 million fund that was designed and launched by British universal bank Barclays plc and Unreasonable Group, a catalytic platform for entrepreneurs tackling some of the world’s most pressing challenges.

With the Impact Squared grant, Twelve and LanzaTech are taking a collaborative approach to reduce the fossil fuel impact of essential products.

We're using cookies. Read more